Citation: Sn. Finkelstein et al., COMMENT - COST COMPARISON OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AND BLOOD-TRANSFUSION IN CANCER CHEMOTHERAPY-INDUCED ANEMIA, The Annals of pharmacotherapy, 31(9), 1997, pp. 1094-1094
Authors:
KATTAN MW
INOUE Y
GILES FJ
TALPAZ M
OZER H
GUILHOT F
ZUFFA E
HUBER SL
BECK JR
Citation: Mw. Kattan et al., COST-EFFECTIVENESS OF INTERFERON-ALPHA AND CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOGENOUS LEUKEMIA, Annals of internal medicine, 125(7), 1996, pp. 541
Citation: Sl. Huber, IMPACT OF CLINICAL-TRIAL PROTOCOLS ON PATIENT-CARE SYSTEMS AT THE UNIVERSITY-OF-TEXAS-MD-ANDERSON-CANCER-CENTER, Cancer, 72(9), 1993, pp. 2824-2827